Variation in Delayed Time to Adjuvant Chemotherapy and Disease-Specific Survival in Stage III Colon Cancer Patients

被引：0
作者：
Adan Z. Becerra
Christopher T. Aquina
Supriya G. Mohile
Mohamedtaki A. Tejani
Maria J. Schymura
Francis P. Boscoe
Zhaomin Xu
Carla F. Justiniano
Courtney I. Boodry
Alex A. Swanger
Katia Noyes
John R. Monson
Fergal J. Fleming
机构：
[1] University of Rochester Medical Center,Division of Epidemiology, Department of Public Health Sciences
[2] University of Rochester Medical Center,Surgical Health Outcomes & Research Enterprise, Department of Surgery
[3] University of Rochester Medical Center,Department of Medicine, Hematology/Oncology
[4] New York State Department of Health,New York State Cancer Registry, Bureau of Cancer Epidemiology
[5] University at Buffalo,Division of Health Services Policy and Practice, Department of Epidemiology and Environmental Health, School of Public Health
[6] Florida Hospital,Center for Colon and Rectal Surgery, Florida Hospital Medical Group
来源：
Annals of Surgical Oncology | 2017年 / 24卷
关键词：
Adjuvant Chemotherapy; Medical Oncologist; Propensity Score Match; Colon Cancer Patient; Statewide Planning;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1610 / 1617
页数：7
相关论文
共 73 条
  • [1] Benson AB(2004)American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer J Clin Oncol. 22 3408-3419
  • [2] Schrag D(2003)Colon cancer clinical practice guidelines in oncology JNCCN. 1 40-53
  • [3] Somerfield MR(1990)Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma N Engl J Med. 322 352-358
  • [4] Engstrom PF(1993)The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03 J Clin Oncol. 11 1879-1887
  • [5] Benson AB(1997)Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer J Clin Oncol. 15 246-250
  • [6] Saltz L(2011)Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analyses J Clin Oncol 29 3768-3774
  • [7] Moertel CG(2004)On behalf of the Multicenter International Study of Oxaliplatin/5-Fluorouracil/Leucovorin in the Adjuvant Treatment of Colon Cancer ( N Engl J Med. 350 2343-2351
  • [8] Fleming TR(2001)) Investigators Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer J Natl Cancer Inst. 93 850-857
  • [9] Macdonald JS(2015)Age and adjuvant chemotherapy use after surgery for stage III colon cancer Surgery 158 692-699
  • [10] Wolmark N(2011)Opportunity lost: adjuvant chemotherapy in patients with stage III colon cancer remains underused Cancer 117 3833-3840
12345678